Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Monneret

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Anti-Cancer Drug Design|May 21, 1999
Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustardR Lougerstay-Madec, J C Florent, C Monneret, et al.
Nucleosides & Nucleotides|August 26, 1998
Heterocyclic nucleoside analogues by cycloaddition reactions of 1-vinylthymine with 1,3-dipolesD R Adams, A S Boyd, R Ferguson, et al.
Nucleosides & Nucleotides|August 5, 1999
"Mixed inhibitors" of HIV-reverse transcriptase: synthesis and antiviral activityR Pontikis, R Note, E Dechaux, et al.
Tetrahedron|April 1, 1970
[Alkaloidal steroids-C. Holantosines A and B, new amino-glyco-steroids isolated from leaves of Holarrhena antidysenterica(Roxb.). Wall. (Apocynacées)]M M Janot, Q Khuong-Huu, C Monneret, et al.
Anti-Cancer Drug Design|May 21, 1999
Doxorubicin prodrugs with reduced cytotoxicity suited for tumour-specific activationS Desbène, H D Van, S Michel, et al.
Leukemia Research|February 1, 1996
Enhanced topoisomerase II-induced DNA breaks and free radical production by a new anthracycline with potent antileukemic activityW Andrivon, J M Saucier, C Auclair, et al.
Journal of Medicinal Chemistry|November 7, 1998
Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611L Daley, Y Guminski, P Demerseman, et al.
Journal of Medicinal Chemistry|January 1, 1989
Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugarsP Roger, C Monneret, J P Fournier, et al.
NMR in Biomedicine|August 29, 2000
Direct in vivo observation of 5-fluorouracil release from a prodrug in human tumors heterotransplanted in nude mice: a magnetic resonance studyJ L Guerquin-Kern, A Volk, E Chenu, et al.
Cancer Research|March 27, 1998
Elucidation of the mechanism enabling tumor selective prodrug monotherapyK Bosslet, R Straub, M Blumrich, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Anti-Cancer Drug Design|May 21, 1999
Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustardR Lougerstay-Madec, J C Florent, C Monneret, et al.
Nucleosides & Nucleotides|August 26, 1998
Heterocyclic nucleoside analogues by cycloaddition reactions of 1-vinylthymine with 1,3-dipolesD R Adams, A S Boyd, R Ferguson, et al.
Nucleosides & Nucleotides|August 5, 1999
"Mixed inhibitors" of HIV-reverse transcriptase: synthesis and antiviral activityR Pontikis, R Note, E Dechaux, et al.
Tetrahedron|April 1, 1970
[Alkaloidal steroids-C. Holantosines A and B, new amino-glyco-steroids isolated from leaves of Holarrhena antidysenterica(Roxb.). Wall. (Apocynacées)]M M Janot, Q Khuong-Huu, C Monneret, et al.
Anti-Cancer Drug Design|May 21, 1999
Doxorubicin prodrugs with reduced cytotoxicity suited for tumour-specific activationS Desbène, H D Van, S Michel, et al.
Leukemia Research|February 1, 1996
Enhanced topoisomerase II-induced DNA breaks and free radical production by a new anthracycline with potent antileukemic activityW Andrivon, J M Saucier, C Auclair, et al.
Journal of Medicinal Chemistry|November 7, 1998
Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611L Daley, Y Guminski, P Demerseman, et al.
Journal of Medicinal Chemistry|January 1, 1989
Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugarsP Roger, C Monneret, J P Fournier, et al.
NMR in Biomedicine|August 29, 2000
Direct in vivo observation of 5-fluorouracil release from a prodrug in human tumors heterotransplanted in nude mice: a magnetic resonance studyJ L Guerquin-Kern, A Volk, E Chenu, et al.
Cancer Research|March 27, 1998
Elucidation of the mechanism enabling tumor selective prodrug monotherapyK Bosslet, R Straub, M Blumrich, et al.
Pageof 6